Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme

Genome Medicine

Volumn 2, Issue 9, 2010, Pages

  Ovaska, Kristian ^a   Laakso, Marko ^a   Haapa Paananen, Saija ^b   Louhimo, Riku ^a   Chen, Ping ^a   Aittomäki, Viljami ^a   Valo, Erkka ^a   Núñez Fontarnau, Javier ^a   Rantanen, Ville ^a   Karinen, Sirkku ^a   Nousiainen, Kari ^a   Lahesmaa Korpinen, Anna Maria ^a   Miettinen, Minna ^a   Saarinen, Lilli ^a   Kohonen, Pekka ^b   Wu, Jianmin ^a   Westermarck, Jukka ^b   Hautaniemi, Sampsa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MOESIN;

ARTICLE; BIOLOGY; CELL PROLIFERATION; CONCEPTUAL FRAMEWORK; DATA ANALYSIS; DATA BASE; DISEASE COURSE; GENE; GENE LOCUS; GENE MUTATION; GENOMICS; GLIOBLASTOMA; HUMAN; KNOWLEDGE; NONHUMAN; PRIORITY JOURNAL;

EID: 78751681684     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm186     Document Type: Article

References (37)

1. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068. 10.1038/nature07385, 2671642, 18772890, Cancer Genome Atlas Research Network.
2. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007, 21:2683-2710. 10.1101/gad.1596707, 17974913.
3. Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, Renfrow JJ, Yadav AK, Vogel H, Scheck AC, Tibshirani R, Sikic BI. A network model of a cooperative genetic landscape in brain tumors. JAMA 2009, 302:261-275. 10.1001/jama.2009.997, 19602686.
4. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Holland E. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 2009, 4:e7752. 10.1371/journal.pone.0007752, 2771920, 19915670.
5. Cerami E, Demir E, Schultz N, Taylor BS, Sander C. Automated network analysis identifies core pathways in glioblastoma. PLoS One 2010, 5:e8918. 10.1371/journal.pone.0008918, 2820542, 20169195.
6. Gaire RK, Bailey J, Bearfoot J, Campbell IG, Stuckey PJ, Haviv I. MIRAGAA - a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer. Bioinformatics 2009, 26:161-167. 10.1093/bioinformatics/btp654, 19933823.
7. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110. 10.1016/j.ccr.2009.12.020, 20129251.
8. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995, 57:289-300.
9. Carvalho B, Bengtsson H, Speed TP, Irizarry RA. Exploration, normalization, and genotype calls of high-density oligonucleotide SNP array data. Biostatistics 2007, 8:485-499. 10.1093/biostatistics/kxl042, 17189563.
10. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004, 5:557-572. 10.1093/biostatistics/kxh008, 15475419.
11. Hautaniemi S, Ringner M, Kauraniemi P, Autio R, Edgren H, Yli-Harja O, Astola J, Kallioniemi A, Kallioniemi OP. A strategy for identifying putative causes of gene expression variation in human cancer. J Jefferson Institute 2004, 341:77-88.
12. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringnér M, Sauter G, Monni O, Elkahloun A, Kallioniemi O-P, Kallioniemi A. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002, 62:6240-6245.
13. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-158. 10.1093/nar/gkm952, 2238936, 17991681.
14. Boutros M, Bras LP, Huber W. Analysis of cell-based RNAi screens. Genome Biol 2006, 7:R66. 10.1186/gb-2006-7-7-r66, 1779553, 16869968.
15. Cleveland W. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979, 74:829-836.
16. Des Rivi J, Wiegand J. Eclipse: a platform for integrating development tools. IBM Syst J 2004, 43:371-383.
17. Anduril. , http://csbi.ltdk.helsinki.fi/anduril/
18. Anduril User Guide. , http://csbi.ltdk.helsinki.fi/anduril/userguide.pdf
19. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
20. Frank E, Hall M, Trigg L, Holmes G, Witten IH. Data mining in bioinformatics using Weka. Bioinformatics 2004, 20:2479-2481. 10.1093/bioinformatics/bth261, 15073010.
21. Laakso M, Hautaniemi S. Integrative platform to translate gene sets to networks. Bioinformatics 2010, 26:1802-1803. 10.1093/bioinformatics/btq277, 20507894.
22. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. GenePattern 2.0. Nat Genet 2006, 38:500-501. 10.1038/ng0506-500, 16642009.
23. Orvis J, Crabtree J, Galens K, Gussman A, Inman JM, Lee E, Nampally S, Riley D, Sundaram JP, Felix V, Whitty B, Mahurkar A, Wortman J, White O, Angiuoli SV. Ergatis: a web interface and scalable software system for bioinformatics workflows. Bioinformatics 2010, 26:1488-1492. 10.1093/bioinformatics/btq167, 2881353, 20413634.
24. Oinn T, Addis M, Ferris J, Marvin D, Senger M, Greenwood M, Carver T, Glover K, Pocock MR, Wipat A, Li P. Taverna: a tool for the composition and enactment of bioinformatics workflows. Bioinformatics 2004, 20:3045-3054. 10.1093/bioinformatics/bth361, 15201187.
25. Anduril generated glioblastoma multiforme result website. , http://csbi.ltdk.helsinki.fi/anduril/tcga-gbm/
26. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36:D480-484. 10.1093/nar/gkm882, 2238879, 18077471.
27. Wu J, Vallenius T, Ovaska K, Westermarck J, Makela TP, Hautaniemi S. Integrated network analysis platform for protein-protein interactions. Nat Methods 2009, 6:75-77. 10.1038/nmeth.1282, 19079255.
28. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics 1998, 14:656-664. 10.1093/bioinformatics/14.8.656, 9789091.
29. Hubbard TJ, Aken BL, Ayling S, Ballester B, Beal K, Bragin E, Brent S, Chen Y, Clapham P, Clarke L, Coates G, Fairley S, Fitzgerald S, Fernandez-Banet J, Gordon L, Graf S, Haider S, Hammond M, Holland R, Howe K, Jenkinson A, Johnson N, Kahari A, Keefe D, Keenan S, Kinsella R, Kokocinski F, Kulesha E, Lawson D, Longden I, et al. Ensembl 2009. Nucleic Acids Res 2009, 37:D690-697. 10.1093/nar/gkn828, 2686571, 19033362.
30. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005, 65:6029-6033. 10.1158/0008-5472.CAN-05-0137, 16024602.
31. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 2007, 67:8994-9000. 10.1158/0008-5472.CAN-07-1045, 17908999.
32. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009, 13:39-53. 10.1111/j.1582-4934.2008.00556.x, 19175699.
33. Lawler S, Chiocca EA. Emerging functions of microRNAs in glioblastoma. J Neurooncol 2009, 92:297-306. 10.1007/s11060-009-9843-2, 19357957.
34. Abba MC, Sun H, Hawkins KA, Drake JA, Hu Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A, Aldaz CM. Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res 2007, 5:881-890. 10.1158/1541-7786.MCR-07-0055, 17855657.
35. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905. 10.1038/nature08822, 2826709, 20164920.
36. Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerda-Nicolas M, Lopez-Gines C. Primary glioblastomas with and without EGFR amplification: Relationship to genetic alterations and clinicopathological features. Neuropathology 2009, 30:392-400. 10.1111/j.1440-1789.2009.01081.x, 20051017.
37. Tran H, Hamada F, Schwarz-Romond T, Bienz M. Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains. Genes Dev 2008, 22:528-542. 10.1101/gad.463208, 2238673, 18281465.